Quantbot Technologies LP Sells 36,891 Shares of Veeva Systems Inc. $VEEV

Quantbot Technologies LP lowered its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 95.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,701 shares of the technology company’s stock after selling 36,891 shares during the quarter. Quantbot Technologies LP’s holdings in Veeva Systems were worth $507,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GPS Wealth Strategies Group LLC lifted its stake in Veeva Systems by 196.4% during the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock worth $25,000 after purchasing an additional 55 shares during the last quarter. Raiffeisen Bank International AG purchased a new position in shares of Veeva Systems during the 3rd quarter valued at about $28,000. OLD Second National Bank of Aurora purchased a new position in shares of Veeva Systems during the 3rd quarter valued at about $30,000. Legacy Investment Solutions LLC bought a new stake in Veeva Systems in the 2nd quarter worth approximately $32,000. Finally, Cary Street Partners Investment Advisory LLC lifted its position in Veeva Systems by 58.3% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock worth $38,000 after buying an additional 49 shares during the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Veeva Systems Stock Down 0.1%

Shares of NYSE VEEV opened at $195.89 on Monday. Veeva Systems Inc. has a 52 week low of $168.13 and a 52 week high of $310.50. The firm’s fifty day moving average is $203.47 and its 200 day moving average is $246.91. The company has a market cap of $32.20 billion, a price-to-earnings ratio of 36.21, a PEG ratio of 1.35 and a beta of 1.09.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. The business had revenue of $835.95 million during the quarter, compared to analysts’ expectations of $810.95 million. Veeva Systems had a net margin of 28.44% and a return on equity of 14.11%. The firm’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.74 EPS. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. Equities research analysts anticipate that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Veeva Systems declared that its board has approved a share buyback plan on Monday, January 5th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the technology company to buy up to 5.5% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling at Veeva Systems

In related news, insider Thomas D. Schwenger sold 1,000 shares of the business’s stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider owned 23,204 shares in the company, valued at $5,370,101.72. The trade was a 4.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 10.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on VEEV shares. BTIG Research reissued a “buy” rating and set a $340.00 price target on shares of Veeva Systems in a research note on Friday, November 21st. Morgan Stanley upped their price objective on shares of Veeva Systems from $205.00 to $215.00 and gave the company an “equal weight” rating in a research note on Thursday. Oppenheimer reduced their target price on shares of Veeva Systems from $325.00 to $275.00 and set an “outperform” rating on the stock in a report on Tuesday, February 24th. Barclays lowered their price target on shares of Veeva Systems from $305.00 to $250.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Finally, Wells Fargo & Company reduced their price objective on Veeva Systems from $333.00 to $317.00 and set an “overweight” rating on the stock in a research note on Thursday. Seventeen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus target price of $284.91.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Q4 beats and raised outlook — Veeva reported revenue of ~$836M (+16% y/y) and non‑GAAP EPS of $2.06, above consensus, and provided FY27 guidance that came in ahead of some estimates, which drove the initial rally. Article Title
• Positive Sentiment: AI and product roadmap cited as growth drivers — Management emphasized “agentic” AI initiatives and CRM expansion (CRM targeted to be ~10% of revenue by 2030), positioning Veeva to capture higher‑value services and offset broader software AI fears. Article Title
• Positive Sentiment: Analyst support and buy ratings remain — Several firms reaffirmed or raised ratings/targets (e.g., Stifel raised target to $245; Truist reaffirmed buy), keeping institutional sentiment constructive despite some cuts. Article Title
• Neutral Sentiment: Earnings call detail available for deeper read — The full Q4 earnings call/transcript provides color on customer uptake, AI timing and margin outlook; useful for investors who want to judge execution risk vs opportunity. Article Title
• Neutral Sentiment: Technical/volume context — Trading volume was a bit below average and the stock remains under its 50‑ and 200‑day moving averages, which can limit near‑term upside until momentum recovers. (See market data summary above.)
• Negative Sentiment: Price‑target cuts and cautious notes — Multiple firms trimmed price targets (Canaccord, Piper Sandler, Needham, RBC, Wells Fargo among others) citing decelerating growth, margin pressure or to reflect model changes—these headlines trimmed upside and likely capped the post‑earnings rally. Article Title
• Negative Sentiment: Ongoing AI disruption debate — Despite Veeva’s positioning, some investors remain worried about how AI will change software economics and competitive dynamics; a few analysts argue AI risk and growth normalization justify a more cautious stance. Article Title

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.